Update interview
16 Jun 2026

MedScan3D
MedScan3D is a medtech company specializing in the production of patient-specific anatomical models. The models are typically replicas of organs and body parts used to support surgical training and medical research. The company is based in the UK. IDTechEx spoke to MedScan3D at Med-Tech Expo 2026.
Full profile interview: Company Financials
31 May 2026

Beta Bionics
Update: Company Financials
31 May 2026

Insulet
Full profile interview: Company Financials
31 May 2026

Tandem Diabetes
Full profile interview
28 May 2026

MiniMed
MiniMed is an independent, newly public medical technology company that leverages advanced, AI-driven closed-loop systems and a high-margin recurring consumable model to automate global diabetes management.
Included are:
Full profile interview
28 May 2026

Dexcom
Dexcom is a US-based biotech company, founded in 1999. The company is one of the market leaders in the continuous glucose monitoring (CGM) industry.
Full profile interview
17 May 2026

Abbott Diabetes Care
Abbott Diabetes Care is a division of American multinational company Abbott Laboratories. Today, Abbott Diabetes Care is a major player in the continuous glucose monitoring market — the company's "Freestyle" brand of continuous glucose monitors (CGMs) is believed to be the most widely used CGM device.
Innovation Map
22 Jan 2025

Development of Closed-Loop Insulin Systems
Innovation map for development of closed-loop insulin systems.
Innovation Map
20 Jan 2025

Insulin Delivery
Innovation map for insulin delivery.
Innovation Map
20 Jan 2025

Continuous Glucose Monitoring
Innovation map of continuous glucose monitoring.
Background
28 Oct 2024

Senseonics
Senseonics is a medical technology company specializing in long-term, implantable continuous glucose monitoring (CGM) systems under the Eversense brand.
Full profile interview
20 Mar 2023

Inreda Diabetic
Inreda Diabetic is a Dutch medical device company, founded by mechanical engineer Robin Koops in 2004 with headquarters in Goor. The company is developing the Inreda Artificial Pancreas (or the Inreda AP) for automatic glucose regulation for diabetes management.